Unilabs Signs Multi-Year Deal With C2N To Expand Alzheimer’s Test In Europe And Beyond
Executive Summary
Unilabs and C2N Diagnostics signed a multi-year agreement that will expand access to C2N’s Alzheimer’s tests in Europe and other countries.
Topics
- Therapy Areas
- Neurology
- Subjects
- Behavioral Health
- Commercial
- Deals
- Research & Development
- Device Areas
- Diagnostics
- In Vitro Diagnostics
- Industries
- Medical Device
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MT155023
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
MT155023
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.